Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Control group: Wrist splint prescription. A wrist splint with a volar metal bar was used at an angle of 0° for 12 weeks. The patients were instructed to wear the splint during the nigh
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients from 30-50 years of age Duration of symptoms for at least 3 months
Exclusion criteria
Exclusion criteria: The presence of other neuropathic diseases such as polyneuropathy, cervical radiculopathy, or brachial plexopathy (including thoracic outlet syndrome) Systemic diseases that can affect the severity or treatment, such as hypothyroidism, gout, systemic lupus erythematosus, rheumatoid arthritis, diabetes mellitus, chronic kidney deficiency, and acromegaly, History of carpal tunnel release surgery, Wrist fracture Pregnancy History of injectionin the carpal tunnel in the last month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the treatment and immediately and 12 weeks after the last treatment session. Method of measurement: Visual analogue scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Grip strenghth. Timepoint: Before the treatment and immediately and 12 weeks after the last treatment session. Method of measurement: Manual dynamometer.;Median nerve conduction study. Timepoint: Before the treatment and immediately and 12 weeks after the last treatment session. Method of measurement: Electrodiagnosis test, by EMG-NCS devices.;Symptoms and function. Timepoint: Before the treatment and immediately and 12 weeks after the last treatment session. Method of measurement: Boston questionnair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Fateme Hojjati
Shahid Beheshti University of Medical Sciences
Outcome results
None listed